Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Exhaled breath profiling in diagnosing wheezy preschool children Source: Eur Respir J 2013; 41: 183-188 Year: 2013
Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020
Exhaled NO, but not CO or breath condensate nitrogen products discriminate between healthy and asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 675s Year: 2005
Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Exhaled carbon monoxide level is higher in steroid naïve asthmatic children comparing to healthy individuals Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Exhaled carbon monoxide level in asthmatic and healthy children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Development of an exhaled breath protein pattern to distinguish asthmatic from healthy children Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010
Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Relationship between exhaled nitric oxide and atopy in asthmatic and non-asthmatic Asian young adults Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003
Total IgE in exhaled air condensate of allergic asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001
Exhaled NO in atopic and non atopic asthma children and in asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 337s Year: 2002
Asthmatic children have similar salivary nitrite levels and oral contribution to exhaled NO as healthy children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study Source: Eur Respir J 2013; 42: 98-106 Year: 2013
Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018